BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

914 related articles for article (PubMed ID: 10025830)

  • 1. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique.
    Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H
    J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mean regional cerebral blood flow images of normal subjects using technetium-99m-HMPAO by automated image registration.
    Imran MB; Kawashima R; Sato K; Kinomura S; Ito H; Koyama M; Goto R; Ono S; Yoshioka S; Fukuda H
    J Nucl Med; 1998 Jan; 39(1):203-7. PubMed ID: 9443762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of automated image registration to generate mean brain SPECT image of Alzheimer's patients.
    Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ito H; Ono S; Yoshioka S; Sato M; Fukuda H
    Ann Nucl Med; 1998 Jun; 12(3):127-32. PubMed ID: 9673712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tc-99m HMPAO SPECT in the evaluation of Alzheimer's disease: correlation between neuropsychiatric evaluation and CBF images.
    Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Sato M; Fukuda H
    J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):228-32. PubMed ID: 10071106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of linearization correction on statistical parametric mapping (SPM): a 99mTc-HMPAO brain perfusion SPECT study in mild Alzheimer's disease.
    Ansar MA; Osaki Y; Kazui H; Oku N; Takasawa M; Kimura Y; Begum NN; Ikejiri Y; Takeda M; Hatazawa J
    Ann Nucl Med; 2006 Oct; 20(8):511-7. PubMed ID: 17134017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
    Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer's disease from controls using brain perfusion SPECT.
    Imabayashi E; Matsuda H; Asada T; Ohnishi T; Sakamoto S; Nakano S; Inoue T
    J Nucl Med; 2004 Sep; 45(9):1450-7. PubMed ID: 15347711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease.
    Defebvre LJ; Leduc V; Duhamel A; Lecouffe P; Pasquier F; Lamy-Lhullier C; Steinling M; Destée A
    J Nucl Med; 1999 Jun; 40(6):956-62. PubMed ID: 10452310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-HMPAO regional cerebral blood flow and quantitative electroencephalography in Alzheimer's disease: a correlative study.
    Rodriguez G; Nobili F; Copello F; Vitali P; Gianelli MV; Taddei G; Catsafados E; Mariani G
    J Nucl Med; 1999 Apr; 40(4):522-9. PubMed ID: 10210209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD.
    Koyama M; Kawashima R; Ito H; Ono S; Sato K; Goto R; Kinomura S; Yoshioka S; Sato T; Fukuda H
    J Nucl Med; 1997 Apr; 38(4):587-92. PubMed ID: 9098207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-guided SPECT measurements of medial temporal lobe blood flow in Alzheimer's disease.
    Julin P; Lindqvist J; Svensson L; Slomka P; Wahlund LO
    J Nucl Med; 1997 Jun; 38(6):914-9. PubMed ID: 9189141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory-provoked rCBF-SPECT as a diagnostic tool in Alzheimer's disease?
    Sundström T; Elgh E; Larsson A; Näsman B; Nyberg L; Riklund KA
    Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):73-80. PubMed ID: 16151770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study.
    Waldemar G; Bruhn P; Kristensen M; Johnsen A; Paulson OB; Lassen NA
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):285-95. PubMed ID: 8158175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities in rCBF and computed tomography in patients with Alzheimer's disease and in controls.
    Wyper D; Teasdale E; Patterson J; Montaldi D; Brown D; Hunter R; Graham D; McCulloch J
    Br J Radiol; 1993 Jan; 66(781):23-7. PubMed ID: 8428246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory functions and rCBF (99m)Tc-HMPAO SPET: developing diagnostics in Alzheimer's disease.
    Elgh E; Sundström T; Näsman B; Ahlström R; Nyberg L
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1140-8. PubMed ID: 12192558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease.
    Herholz K; Schopphoff H; Schmidt M; Mielke R; Eschner W; Scheidhauer K; Schicha H; Heiss WD; Ebmeier K
    J Nucl Med; 2002 Jan; 43(1):21-6. PubMed ID: 11801698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting regional cerebral blood flow changes in Alzheimer's patients after milameline treatment: activation or baseline SPECT?
    Zheng XM
    J Nucl Med Technol; 2002 Sep; 30(3):118-22. PubMed ID: 12186960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.